Table 2 Characteristics of control patients with chronic hepatitis C
From: Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
Subject # | Age (Years) | Risk factor | Duration of IVDU (months) | Peak ALT (U/L) | Peak HCV viremia (IU/ml) | Anti-HCV-antibodies ELISA | Genotype |
|---|---|---|---|---|---|---|---|
4 | 18 | IVDU | 6 | 168 | 1 × 106 | Positive | 3 |
12 | 18 | IVDU | 27 | 34 | 2 × 105 | Positive | 2 |
14 | 19 | IVDU | 18 | 44 | 2 × 106 | Positive | 1 |
29 | 20 | IVDU | 36 | 21 | 2 × 106 | Positive | 1 |
31 | 18 | IVDU | 72 | 715 | 9 × 106 | Positive | 1 |
32 | 20 | IVDU | 24 | 57 | 3 × 106 | Positive | 3 |
44 | 21 | IVDU | 84 | 49 | 4 × 105 | Positive | 2 |
48 | 22 | Unsafe Sex | n.a. | 13 | 4 × 105 | Positive | 1 |
56 | 22 | IVDU | 60 | 193 | 1 × 106 | Positive | 1 |
57 | 22 | IVDU | 36 | 34 | 2 × 106 | Positive | 1 |
69 | 21 | IVDU | 36 | 94 | 1 × 104 | Positive | 3 |